NCT04501874 - A Study to Evaluate EMB 001 in Subjects With Cocaine Use Disorder | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 29, 2020

Primary Completion Date

July 27, 2022

Study Completion Date

October 15, 2022

Conditions

Cocaine Use Disorder

Interventions

DRUG

EMB-001

720 mg metyrapone/24 mg oxazepam mg BID

DRUG

EMB-001 Placebo

Inactive comparator

Trial Locations (4)

U PENN- Perelman School of Medicine, Philadelphia

Medical University of South Carolina, Charleston

Segal Trials, Miami

Pacific Treatment and Research Center, Department of Psychiatry, University of California, San Diego, School of Medicine, San Diego